Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JAFARI REZA; MAJIDI ZOLBANIN NAIME; MAJIDI JAFAR; ATYABI FATEMEH; YOUSEFI MEHDI; JADIDI NIARAGH FARHAD; AGHEBATI MALEKI LEILI; SHANEHBANDI DARIUSH; SOLTANI ZANGBAR MOHAMMAD SADEGH; RAFATPANAH HOUSHANG

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Biomedical Journal Year:2019 | Volume:23 | Issue:1 Page(s): 21-33

Download Full-Text

View:

130

Download:

103

Cites:

Information Journal Paper

Title

Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells

Author(s)

Keywords

Breast cancer therapy

Chitosan nanoparticles

Docetaxel

IGF-1R siRNA

MUC1 aptamer

Abstract

Background: Targeted co-delivery of siRNA and a chemotherapeutic drug is an attractive approach to cancer drug design and treatment. This study was carried out to design an anti-Mucin1 aptamer (Apt)-conjugated chitosan nanoparticle (NP) for targeted co-delivery of insulin-like growth factor receptor 1 (IGF-1R) Silencer siRNA and Docetaxel (DTX) to SKBR3 cells. Methods: Characterization of nano-drugs, cellular uptake of NPs, cell viability, and gene expression studies were evaluated based on metastatic breast cancer cells. Results: The results of this study showed that NPs had spherical and smooth morphology with 110-118 nm in size and had positive zeta potential (12-14 mV). siRNA and DTX were considerably loaded into NPs. The appropriate conjugation of the Apt to the NPs was affirmed by gel electrophoresis. The Apt-conjugated NPs were observed to enhance the cellular uptake of NPs into the SKBR3 cells. Although the combination treatment significantly decreased the cell viability of SKBR3 cells, the augmentative effect was observed when Apt was conjugated to NPs. Furthermore, Apt-conjugated NPs dramatically reduced the genetic expression of IGF-1R, signal transducers and activators of transcription 3 (STAT3), matrix metalloproteinases (MMP9), and vascular growth factor (VEGF). Conclusion: The targeted NPs may augment the targeting of pathways involved in tumorigenesis and metastasis of breast cancer. Therefore, more animal model experiments are needed to further clarify the efficacy and safety of this functionalized nanodrug.

Cites

No record.

References

No record.

Cite

APA: Copy

JAFARI, REZA, MAJIDI ZOLBANIN, NAIME, MAJIDI, JAFAR, ATYABI, FATEMEH, YOUSEFI, MEHDI, JADIDI NIARAGH, FARHAD, AGHEBATI MALEKI, LEILI, SHANEHBANDI, DARIUSH, SOLTANI ZANGBAR, MOHAMMAD SADEGH, & RAFATPANAH, HOUSHANG. (2019). Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells. IRANIAN BIOMEDICAL JOURNAL, 23(1), 21-33. SID. https://sid.ir/paper/758080/en

Vancouver: Copy

JAFARI REZA, MAJIDI ZOLBANIN NAIME, MAJIDI JAFAR, ATYABI FATEMEH, YOUSEFI MEHDI, JADIDI NIARAGH FARHAD, AGHEBATI MALEKI LEILI, SHANEHBANDI DARIUSH, SOLTANI ZANGBAR MOHAMMAD SADEGH, RAFATPANAH HOUSHANG. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells. IRANIAN BIOMEDICAL JOURNAL[Internet]. 2019;23(1):21-33. Available from: https://sid.ir/paper/758080/en

IEEE: Copy

REZA JAFARI, NAIME MAJIDI ZOLBANIN, JAFAR MAJIDI, FATEMEH ATYABI, MEHDI YOUSEFI, FARHAD JADIDI NIARAGH, LEILI AGHEBATI MALEKI, DARIUSH SHANEHBANDI, MOHAMMAD SADEGH SOLTANI ZANGBAR, and HOUSHANG RAFATPANAH, “Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells,” IRANIAN BIOMEDICAL JOURNAL, vol. 23, no. 1, pp. 21–33, 2019, [Online]. Available: https://sid.ir/paper/758080/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops